Stonebridge Capital Advisors’s Axogen AXGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AXGN
ACH
EWM
Stonebridge Capital Advisors's AXGN Position: Q2 2020 in Review
Stonebridge Capital Advisors sold out of Axogen (AXGN) in Q2 2020, closing a stake of 2,000 shares — an estimated $21K sold.
Stonebridge Capital Advisors first reported a position in AXGN in Q2 2019 and held it in 4 quarters. The position peaked at $59K in Q2 2019. 114 funds tracked by Wall St. Rank hold AXGN as of Q2 2020.
- Stonebridge Capital Advisors reported no remaining Axogen position as of Q2 2020 after selling out during the quarter.
- Stonebridge Capital Advisors sold 2,000 Axogen shares in Q2 2020, an estimated $21K.
- Stonebridge Capital Advisors first reported a position in Axogen in Q2 2019 and held it in 4 quarters.
- Stonebridge Capital Advisors's Axogen position peaked at $59K in Q2 2019.
- 114 funds tracked by Wall St. Rank held Axogen as of Q2 2020.
Based on Stonebridge Capital Advisors's 13F filing for Q2 2020, filed 13 Aug 2020.